Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$951.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Jun 1 | GLUE | Monte Rosa Therapeutics,… | SSELL◷ | 4,998 | $19.41 | $97K | -0.8% | Open the original filing on SEC.gov |
| May 1 | GLUE | Monte Rosa Therapeutics,… | SSELL◷ | 5,467 | $18.92 | $103.4K | -0.9% | Open the original filing on SEC.gov |
| Apr 14 | GLUE | Monte Rosa Therapeutics,… | SSELL | 8,000 | $17.64 | $141.1K | -1.3% | Open the original filing on SEC.gov |
| Mar 2 | GLUE | Monte Rosa Therapeutics,… | SSELL◷ | 5,466 | $17.92 | $98K | -0.9% | Open the original filing on SEC.gov |
| Jan 7 | GLUE | Monte Rosa Therapeutics,… | SSELL◷ | 309 | $24.57 | $7.6K | <0.1% | Open the original filing on SEC.gov |
| Jan 7 | GLUE | Monte Rosa Therapeutics,… | SSELL◷ | 1,450 | $23.88 | $34.6K | -0.2% | Open the original filing on SEC.gov |
| Jan 7 | GLUE | Monte Rosa Therapeutics,… | SSELL◷ | 3,707 | $23.24 | $86.2K | -0.6% | Open the original filing on SEC.gov |
| Jan 5 | GLUE | Monte Rosa Therapeutics,… | SSELL | 10,135 | $15.17 | $153.7K | -1.6% | Open the original filing on SEC.gov |
| Jan 2 | GLUE | Monte Rosa Therapeutics,… | AGRANT◆ | 406,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | GLUE | Monte Rosa Therapeutics,… | AGRANT | 90,000 | — | — | +16.5% | Open the original filing on SEC.gov |